Lars Staal Wegner MD
General Partner at Bristlecone Pacific- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Full professional proficiency
-
Danish Native or bilingual proficiency
-
Norwegian Professional working proficiency
-
sweedish Limited working proficiency
Topline Score
Bio
Henrik Birk
I worked with Lars for 6 years at Bavarian Nordic, where Lars served in the capacity of Vice President Commerical Affairs. During this period I came to know Lars as a truly professional, dedicated and experienced senior executive. Lars is highly motivated and sets the standard for his personal leadership very high. He challenges himself and his organization to deliver the best results, often in difficult environments with limited resources and compressed timelines. As a leader, Lars leads by example and adapts his leadership style to the current situation. Lars would be a strong asset to any company and I give him my warmest recommendations.
Tom Wylonis
Lars and I know one another very well. Together with the two founders of Evaxion, we act as a 'real' team with complementary leadership skills needed to make Evaxion a ground-breaking success in using Artificial Intelligence (AI) to discover of cancer-vaccine therapies and infectious bacteria vaccines. In January 2014 Lars was elected as the Founding Chairman of Evaxion, and I joined the board as a member. In January 2015, I was elected as Chairman of the Board, while Lars continued to serve on the board while working full time as an executive at Bavarian Nordic. In July 2017, Lars, sensing a 'once-in-a-lifetime' opportunity, became Evaxion's Chief Executive Officer (CEO) while I continued as Chairman. Lars is an outstanding CEO of a growing, knowledge-based, biotech company. Together with the team, Lars led the formulation of an aspiration, a strategy and shared values that have guided the company since he became CEO. He has become skilled in motivating employees who have advanced degrees & R&D experience - e.g. by reinforcing a project-based, organizational meritocracy that avoids hierarchy and functional silos. He has successfully led capital raising for the company since election to the board due to his prodigious professional network. And he has the technical background, e.g. vaccine R&D, oncology, infectious disease, needed to coach less-experienced employees as they push back the frontiers of application of AI to immune-oncology and bacterial vaccine discovery and development. All of this is happening while, or because, Lars maintains a trust-based, meritocratic and motivating work environment.
Henrik Birk
I worked with Lars for 6 years at Bavarian Nordic, where Lars served in the capacity of Vice President Commerical Affairs. During this period I came to know Lars as a truly professional, dedicated and experienced senior executive. Lars is highly motivated and sets the standard for his personal leadership very high. He challenges himself and his organization to deliver the best results, often in difficult environments with limited resources and compressed timelines. As a leader, Lars leads by example and adapts his leadership style to the current situation. Lars would be a strong asset to any company and I give him my warmest recommendations.
Tom Wylonis
Lars and I know one another very well. Together with the two founders of Evaxion, we act as a 'real' team with complementary leadership skills needed to make Evaxion a ground-breaking success in using Artificial Intelligence (AI) to discover of cancer-vaccine therapies and infectious bacteria vaccines. In January 2014 Lars was elected as the Founding Chairman of Evaxion, and I joined the board as a member. In January 2015, I was elected as Chairman of the Board, while Lars continued to serve on the board while working full time as an executive at Bavarian Nordic. In July 2017, Lars, sensing a 'once-in-a-lifetime' opportunity, became Evaxion's Chief Executive Officer (CEO) while I continued as Chairman. Lars is an outstanding CEO of a growing, knowledge-based, biotech company. Together with the team, Lars led the formulation of an aspiration, a strategy and shared values that have guided the company since he became CEO. He has become skilled in motivating employees who have advanced degrees & R&D experience - e.g. by reinforcing a project-based, organizational meritocracy that avoids hierarchy and functional silos. He has successfully led capital raising for the company since election to the board due to his prodigious professional network. And he has the technical background, e.g. vaccine R&D, oncology, infectious disease, needed to coach less-experienced employees as they push back the frontiers of application of AI to immune-oncology and bacterial vaccine discovery and development. All of this is happening while, or because, Lars maintains a trust-based, meritocratic and motivating work environment.
Henrik Birk
I worked with Lars for 6 years at Bavarian Nordic, where Lars served in the capacity of Vice President Commerical Affairs. During this period I came to know Lars as a truly professional, dedicated and experienced senior executive. Lars is highly motivated and sets the standard for his personal leadership very high. He challenges himself and his organization to deliver the best results, often in difficult environments with limited resources and compressed timelines. As a leader, Lars leads by example and adapts his leadership style to the current situation. Lars would be a strong asset to any company and I give him my warmest recommendations.
Tom Wylonis
Lars and I know one another very well. Together with the two founders of Evaxion, we act as a 'real' team with complementary leadership skills needed to make Evaxion a ground-breaking success in using Artificial Intelligence (AI) to discover of cancer-vaccine therapies and infectious bacteria vaccines. In January 2014 Lars was elected as the Founding Chairman of Evaxion, and I joined the board as a member. In January 2015, I was elected as Chairman of the Board, while Lars continued to serve on the board while working full time as an executive at Bavarian Nordic. In July 2017, Lars, sensing a 'once-in-a-lifetime' opportunity, became Evaxion's Chief Executive Officer (CEO) while I continued as Chairman. Lars is an outstanding CEO of a growing, knowledge-based, biotech company. Together with the team, Lars led the formulation of an aspiration, a strategy and shared values that have guided the company since he became CEO. He has become skilled in motivating employees who have advanced degrees & R&D experience - e.g. by reinforcing a project-based, organizational meritocracy that avoids hierarchy and functional silos. He has successfully led capital raising for the company since election to the board due to his prodigious professional network. And he has the technical background, e.g. vaccine R&D, oncology, infectious disease, needed to coach less-experienced employees as they push back the frontiers of application of AI to immune-oncology and bacterial vaccine discovery and development. All of this is happening while, or because, Lars maintains a trust-based, meritocratic and motivating work environment.
Henrik Birk
I worked with Lars for 6 years at Bavarian Nordic, where Lars served in the capacity of Vice President Commerical Affairs. During this period I came to know Lars as a truly professional, dedicated and experienced senior executive. Lars is highly motivated and sets the standard for his personal leadership very high. He challenges himself and his organization to deliver the best results, often in difficult environments with limited resources and compressed timelines. As a leader, Lars leads by example and adapts his leadership style to the current situation. Lars would be a strong asset to any company and I give him my warmest recommendations.
Tom Wylonis
Lars and I know one another very well. Together with the two founders of Evaxion, we act as a 'real' team with complementary leadership skills needed to make Evaxion a ground-breaking success in using Artificial Intelligence (AI) to discover of cancer-vaccine therapies and infectious bacteria vaccines. In January 2014 Lars was elected as the Founding Chairman of Evaxion, and I joined the board as a member. In January 2015, I was elected as Chairman of the Board, while Lars continued to serve on the board while working full time as an executive at Bavarian Nordic. In July 2017, Lars, sensing a 'once-in-a-lifetime' opportunity, became Evaxion's Chief Executive Officer (CEO) while I continued as Chairman. Lars is an outstanding CEO of a growing, knowledge-based, biotech company. Together with the team, Lars led the formulation of an aspiration, a strategy and shared values that have guided the company since he became CEO. He has become skilled in motivating employees who have advanced degrees & R&D experience - e.g. by reinforcing a project-based, organizational meritocracy that avoids hierarchy and functional silos. He has successfully led capital raising for the company since election to the board due to his prodigious professional network. And he has the technical background, e.g. vaccine R&D, oncology, infectious disease, needed to coach less-experienced employees as they push back the frontiers of application of AI to immune-oncology and bacterial vaccine discovery and development. All of this is happening while, or because, Lars maintains a trust-based, meritocratic and motivating work environment.
Experience
-
Bristlecone Pacific
-
Canada
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
General Partner
-
Jan 2023 - Present
-
-
-
gMendel
-
Denmark
-
Biotechnology
-
1 - 100 Employee
-
Chairman of the Board
-
Nov 2022 - Present
-
-
-
-
Investor, Board member and AI-biotech Executive
-
Sep 2022 - Present
-
-
-
HowToRobot.com
-
Denmark
-
Information Services
-
1 - 100 Employee
-
Board Member
-
Dec 2021 - Present
-
-
-
Gain & Co
-
Denmark
-
Business Consulting and Services
-
1 - 100 Employee
-
Board Member
-
Dec 2021 - Present
-
-
-
raffle.ai
-
Denmark
-
Software Development
-
1 - 100 Employee
-
Investor
-
Jan 2021 - Present
-
-
-
PII Guard
-
Denmark
-
Data Security Software Products
-
1 - 100 Employee
-
Advisor and Investor
-
Jan 2019 - Present
-
-
-
Plex Research
-
United States
-
IT Services and IT Consulting
-
1 - 100 Employee
-
Investor
-
Jan 2019 - Present
-
-
-
FORM
-
Canada
-
Consumer Electronics
-
1 - 100 Employee
-
Investor
-
Jan 2017 - Present
-
-
-
Copenhagen United
-
Denmark
-
Venture Capital and Private Equity Principals
-
Investor
-
Sep 2014 - Present
-
-
-
Rhino
-
Canada
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
Investor
-
Apr 2016 - Present
-
-
-
Evaxion Biotech A/S
-
Denmark
-
Biotechnology Research
-
1 - 100 Employee
-
CEO Evaxion Biotech
-
Jun 2017 - Sep 2022
US Nasdaq listed AI-biotech company, using Artificial intelligence, super computers and big data to fight cancer and infectious diseases.
-
-
Member of the Board
-
Nov 2013 - Jun 2017
Evaxion Biotech is pioneering rapid and accurate in silico identification of novel protein antigen vaccines for the prevention of infectious diseases. www.evaxion-biotech.com
-
-
-
-
Chairman of the Board
-
Jan 2010 - Aug 2018
byform is a company that provide city furniture for the building industry byform is a company that provide city furniture for the building industry
-
-
-
Bavarian Nordic
-
Denmark
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Vice President Commercial Affairs (Sales, Marketing and Business Development)
-
Oct 2010 - Jun 2017
I was proud of being part of bringing a new Ebola vaccine into the world, a joint effort that brought a vaccine from the preclinic to phase III in 9 months, and millions of doses available. Setting up collaborations with talented partners, such as JNJ, Roche, BMS, NIH, NCI and having the honor of working with a very talented team, that thinks bigger than life.
-
-
Director Sales and Governmental Affairs, Europe and Asia
-
Aug 2008 - Sep 2010
-
-
Medical Marketing Director
-
Aug 2007 - Aug 2008
-
-
-
Codesealer A/S
-
Denmark
-
Computer and Network Security
-
1 - 100 Employee
-
Board Member
-
Sep 2010 - Jun 2016
CodeSealer is an IT-security company with a unique technology platform, that features proprietary Sealed Code and Sealed HTML technologies. The product, CodeSealer Web Session Firewall, which is a proprietary, IP protected, server-based technology for protecting web-banking services from attacks launched by malware installed on the end-users computer. CodeSealer is an IT-security company with a unique technology platform, that features proprietary Sealed Code and Sealed HTML technologies. The product, CodeSealer Web Session Firewall, which is a proprietary, IP protected, server-based technology for protecting web-banking services from attacks launched by malware installed on the end-users computer.
-
-
-
Recon Instruments
-
Canada
-
Consumer Electronics
-
1 - 100 Employee
-
Founding Investor
-
Feb 2009 - Aug 2014
Recon Instruments is the world-leading developer of customized solutions for direct-to-eye communication of real-time information. Was sold to Intel in 2014. Recon Instruments is the world-leading developer of customized solutions for direct-to-eye communication of real-time information. Was sold to Intel in 2014.
-
-
-
Pfizer
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Brand Manager Pfizer Oncology
-
Apr 2007 - Jul 2007
-
-
Medical Advisor Pfizer Oncology/Marketing
-
Feb 2007 - Apr 2007
-
-
Product specialist/Brand Manager
-
May 2006 - Jan 2007
-
-
-
-
Medical Doctor
-
Sep 2004 - May 2006
-
-
-
-
Medical Doctor
-
Mar 2003 - Sep 2004
-
-
Education
-
2013 - 2013
Harvard Business School
Authentic Leadership Program -
2011 - 2011
IMD (International Institute for Management Development) - Business Programs
BPSE (Breakthrough Program for Senior Executives) -
1995 - 2002
Syddansk Universitet
Master (MD), Medicine -
1993 - 1995
Military School, Royal Danish Medical Rangers
Sergeant, Medical Rangers
Community
